Navigation Links
Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study,Results at the American Society of Clinical Oncology Annual Meeting

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--May 24, 2007 - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) announced today that it will report results from a Phase I pharmacologic trial of sapacitabine (CYC682), a novel orally-available nucleoside analog, in patients with advanced leukemias or myelodysplastic syndromes (MDS), at the American Society of Clinical Oncology's (ASCO) Annual Meeting at McCormick Place in Chicago. Details of the presentation are as follows:

Abstract # 7063, Poster # M8

Phase I study of sapacitabine, an oral nucleoside analogue, in patients with advanced leukemias or myelodysplastic syndromes.

General Poster Session: Saturday, June 2, 2007, 8:00 AM - 12:00 pm Central Time

Presenters: Dr. Hagop Kantarjian, Professor of Medicine and Chairman, Department of Leukemia and Dr. William Plunkett, Professor and Chief, Section of Molecular and Cellular Oncology, Department of Experimental Therapeutics both at the University of Texas M.D. Anderson Cancer Center (UTMDACC) in Houston, Texas.

About Cyclacel Pharmaceuticals, Inc.

Cyclacel is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Two Cyclacel drugs are in Phase II trials: sapacitabine (CYC682), an orally-available, cell cycle modulating nucleoside analog, for the treatment of cutaneous T-cell lymphoma (CTCL) and seliciclib (CYC202), an orally-available CDK (cyclin dependent kinase) inhibitor, for the treatment of lung cancer. Sapacitabine is also in Phase I trials in patients with hematologic malignancies. CYC116, an orally-available, Aurora kinase and VEGFR2 inhibitor, is at the IND stage. Several additional programs are at an earlier stage.

Please visit http://www.cyclacel.com/cyc/investors/news/pressreleases for additional information.

Note: The Cyclacel
'"/>




Page: 1 2 3

Related medicine technology :

1. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
2. Cyclacel Pharmaceuticals to Present Preclinical Data on Sapacitabine and Seliciclib at AACR
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:5/20/2013)... /PRNewswire-iReach/ -- It is no secret that Americans have an ... obese gyms and supplement companies are in line to make ... related to dietary issues and a lack of physical activity ... glandular problem or even a vitamin deficiency. (Photo: ... a lack of vitamin b12 . The vitamin is ...
(Date:5/20/2013)... May 20, 2013   National Community Pharmacists Association ... , RPh, MBA issued the following statement today regarding ... Medicare Part D "preferred pharmacy" drug plans , ... the plan,s lowest advertised co-payments: (Logo:  ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- Today at American Society ... Christine Ginocchio discussed Specific Technologies blood ... identification of microorganisms producing bloodstream infection. Dr. Ginocchio ... the Division of Infectious Disease Diagnostics at North ... non-sectarian health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... 1 InterMune, Inc. (Nasdaq: ITMN ) today announced ... InterMune, will present at the Fourth Annual JMP Securities Healthcare ... 3:30 p.m. EDT. , To access a live ... may log on to the investor relations page of InterMune,s ...
... announced today that it has entered into a binding agreement ... Fovea has a portfolio of three clinical compounds, a unique ... the eye diseases. The deal is valued to a total ... milestone payments related to the progress of the clinical compounds. ...
Cached Medicine Technology:Fovea Pharmaceuticals to be Acquired by sanofi-aventis 2
(Date:5/21/2013)... May 21, 2013 STAR (Sensory ... for children with sensory challenges and the Sensory ... research, education and advocacy of Sensory Processing Disorder present ... Strategies to Improve Quality of Life, a two-hour lecture ... University, Pennsylvania. , Learn a method that can ...
(Date:5/21/2013)... Children using the abutment-free implantable ... audiological results comparable to the traditionally used, competitive ... according to a new study. , “The results ... technology performs just as well as technology with ... complications,” says Jim Kasic, president and CEO of ...
(Date:5/21/2013)... As the summer season kicks off, millions of kids ... practice for summer or fall sports. In many cases, ... can begin. , To help parents during this busy time, ... or camp physicals at just $29. As part ... medical history, perform a physical exam and complete required forms. ...
(Date:5/21/2013)... Adeptia, a leading provider of innovative cloud and ... the featured company in an impact report written and ... Bets on Converged Cloud Integration and Process-Orchestration Suites,” offers ... pricing, customers and competition. , “For organizations ... and process orchestration, especially when price, ease of use ...
(Date:5/21/2013)... York, NY (PRWEB) May 21, 2013 Diehard ... two international powerhouse teams - the game between ... coming 23rd of May 2013. These two teams are ... and they are bringing their A-game to the Busch Stadium, ... , This will be the first time that a professional ...
Breaking Medicine News(10 mins):Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:MedSpring Offers Affordable Youth Physicals for $29 2Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2
... 2 (HealthDay News) -- The sale of pet turtles was ... small reptiles are still available and continue to infect young ... the health danger, pet turtles are inappropriate pets in homes ... women, seniors and those with weak immune systems, according to ...
... the development of Alzheimer,s disease is a change in ... In normal brains, tau is present in individual units ... brains, by contrast, tau proteins aggregate into twisted structures ... hallmark of the disease, but their precise role in ...
... AURORA, Colo. (Feb. 2, 2012) Different kinds of ... fundamentally different diseases. According to a University of Colorado ... official journal of the American Cancer Society, different subgroups ... of spread in the body. The study ...
... reason the prognosis for metastatic colon cancer has gone from ... Unfortunately, the drug can also carry with it debilitating neurological ... and needles in fingers and toes and can leave patients ... don,t receive the necessary dose to try to keep their ...
... THURSDAY, Feb. 2 (HealthDay News) -- A warning to certain ... a need to please others are more likely to eat ... "People pleasers feel more intense pressure to eat when they ... comfortable," study lead author Julie Exline, a psychologist at Case ...
... News) -- U.S. researchers believe they,ve discovered how ... other plant products -- provides health benefits. The ... the debate about resveratrol,s biochemistry and could advance efforts ... a therapy for diverse diseases such as type 2 ...
Cached Medicine News:Health News:Pet Turtles Carry Salmonella Dangers, CDC Warns 2Health News:Untangling the mysteries of Alzheimer's 2Health News:New research confirms need for lung cancer testing 2Health News:Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer 2Health News:'People Pleasers' More Prone to Overeating: Study 2Health News:Scientists May Be Closer to Developing 'Red Wine' Drug 2
Cold light source triple outlet....
Cold light source dual outlet....
With the LX300, you don't have to compromise the quality of your lighting system to meet your budget needs. You get the best and whitest light possible from an affordable 300 Watt light source....
The Carl Zeiss Head-worn Loupes L and LC are the ideal solution if a low magnification suffices for your work and you want to keep your hands free to perform the task at hand....
Medicine Products: